A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland-Reference-Cited by-同舟云学术

A population-based cohort of young women diagnosed with breast cancer in Geneva, Switzerland

Published:2019-09-06 Issue:9 Volume:14 Page:e0222136
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Schaffar Robin^ORCID,Bouchardy Christine,Chappuis Pierre Olivier,Bodmer Alexandre,Benhamou Simone,Rapiti Elisabetta

Funder

Swiss Cancer League

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Stewart BW, Wild C, International Agency for Research on Cancer, World Health Organization, editors. World cancer report 2014. Lyon, France: International Agency for Research on Cancer; 2014.

2. Breast cancer in younger women in Switzerland 1996–2009: A longitudinal population-based study;A Bodmer;The Breast,2015

3. Breast cancer incidence trends in European women aged 20–39 years at diagnosis;DF Merlo;Breast Cancer Res Treat,2012

4. Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years;KE Malone;Cancer Res,2006

5. Do young breast cancer patients have worse outcomes?;MA Maggard;J Surg Res,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of first recurrence after treatment in a population-based cohort of young women with breast cancer;Breast Cancer Research and Treatment;2024-04-30

2. Comparison between the Young and Elderly Diagnosed Patients of Carcinoma of the Breast;Pakistan Journal of Health Sciences;2024-01-31

3. Incidence and temporal patterns of true recurrences and second primaries in women with breast cancer: a 10-year competing risk-adjusted analysis;2023-08-29

4. Comparison of Long-Term Oncological Results in Young Women with Breast Cancer between BRCA-Mutation Carriers Versus Non-Carriers: How Tumor and Genetic Risk Factors Influence the Clinical Prognosis;Cancers;2023-08-19

5. Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting;Cancers;2023-08-10